Clinical Trial Update: Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating potential drug interactions between doravirine and estradiol or spironolactone in healthy transgender women; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)
• ESTRADIOL (Estradiol)
• Spironolactone (spironolactone)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Transgender Health, Gender Dysphoria | Phase 1 | Status: COMPLETED | Results posted: 2025-03-26